Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Vesole DH, Bilotti E, Richter JR, McNeill A, McBride L, Raucci L, Anand P, Bednarz U, Ivanovski K, Smith J, Batra V, Aleman A, Sims T, Guerrero L, Mato A, Siegel DS.
Vesole DH, et al. Among authors: mcneill a.
Br J Haematol. 2015 Oct;171(1):52-9. doi: 10.1111/bjh.13517. Epub 2015 May 27.
Br J Haematol. 2015.
PMID: 26018491
Free article.
Clinical Trial.